The DNA Bowel Cancer Screening Kits Market is experiencing substantial growth as healthcare systems increasingly emphasize early cancer detection, preventive healthcare, and non-invasive diagnostic solutions. DNA bowel cancer screening kits are designed to identify genetic and molecular markers associated with colorectal cancer and precancerous conditions through stool-based testing, offering a...

The global Solid-State Nanopore Market is entering a transformative phase as breakthroughs in genomics, molecular diagnostics, and single-molecule analysis continue to reshape scientific research and healthcare applications. Valued at USD 582.7 million in 2024, the market is projected to grow from USD 665.5 million in 2025 to an impressive USD 2.5 billion by 2035, registering a robust...

The global Targeted Protein Degradation Market is experiencing unprecedented growth as biotechnology companies and pharmaceutical developers embrace innovative approaches to treating complex diseases. According to Polaris Market Research, the market generated USD 541.98 million in 2024 and is forecast to reach USD 3,547.91 million by 2034, growing at a 20.7% CAGR over the forecast period. The...

Market Overview The U.S. Rare Disease Diagnostics Market is evolving rapidly due to the increasing recognition of rare diseases as a major public health concern. More than 7,000 rare diseases have been identified globally, with a significant proportion affecting pediatric populations. However, diagnostic delays remain a major challenge, often taking several years due to limited awareness...

According to a new report from Intel Market Research, the global Biological Agent Detection (PCR, Immunoassay) Device market was valued at USD 4.4 billion in 2025 and is projected to reach USD 9.9 billion by 2034, growing at a robust CAGR of 9.7% during the forecast period (2026–2034). This growth is propelled by rising global investments in biodefense programs, heightened concern over...